共 83 条
- [1] Al Raiisi F(2019)Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review Int J Clin Pharm 41 630-66
- [2] Stewart D(2013)Improving global outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease Kidney Int 3 1-150
- [3] Fernandez-Llimos F(2016)Global prevalence of chronic kidney disease - A systematic review and Meta- analysis PLoS ONE 11 e0158765-71
- [4] Hill NR(2011)A population-based survey of chronic REnal Disease in Turkey–the CREDIT study Nephrol Dial Transplant 26 1862-305
- [5] Fatoba ST(2004)Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 1296-58
- [6] Oke JL(2011)Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review BMC Nephrol 12 35-4
- [7] Suleymanlar G(2021)Drug-related problems in Hospitalised patients with chronic kidney disease: a systematic review Drug Saf 44 1041-24
- [8] Utas C(1994)Chronic hemodialysis patients. Part II: reducing drug-related problems through application of the focused drug therapy review program Ann Pharmacother 28 320-37
- [9] Arinsoy T(2002)Analysis of drug prescription in chronic haemodialysis patients Nephrol Dial Transplant 17 1819-9
- [10] Go AS(2009)Implementation of a pharmacist medication review clinic for haemodialysis patients N Z Med J 122 25-9